RENVELA
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $25,664 | 8 | 1 |
| 2018 | $266.62 | 14 | 14 |
| 2017 | $132,149 | 2,266 | 1,246 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $79,829 | 10 | 50.5% |
| Food and Beverage | $40,183 | 2,244 | 25.4% |
| Travel and Lodging | $27,238 | 24 | 17.2% |
| Unspecified | $5,498 | 7 | 3.5% |
| Consulting Fee | $5,332 | 3 | 3.4% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease | GENZYME CORPORATION | $5,498 | 7 |
Top Doctors Receiving Payments for RENVELA — Page 11
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Internal Medicine | Hamilton, NJ | $46.28 | 2 |
| , MD | Nephrology | Jonesboro, AR | $46.27 | 3 |
| , MD | Nephrology | Aiken, SC | $46.13 | 2 |
| , D.O | Nephrology | Aiken, SC | $46.13 | 2 |
| , M.D | Nephrology | Crowley, LA | $46.05 | 3 |
| , M.D | Nephrology | Los Angeles, CA | $45.99 | 2 |
| , DO | Nephrology | Kansas City, MO | $45.93 | 2 |
| , M.D | Specialist | Jersey City, NJ | $45.71 | 3 |
| , MD | Nephrology | Jersey City, NJ | $45.71 | 3 |
| , M.D | Internal Medicine | Woodbridge, NJ | $45.71 | 3 |
| , M.D | Nephrology | Inglewood, CA | $45.50 | 3 |
| , M.D | Nephrology | Cedar Park, TX | $45.48 | 2 |
| , DO | Internal Medicine | Livonia, MI | $45.46 | 3 |
| , MD | Nephrology | Pensacola, FL | $45.38 | 2 |
| , M.D | Nephrology | New Braunfels, TX | $45.35 | 4 |
| , MD | Nephrology | Wilson, NC | $45.22 | 3 |
| , MD | Student in an Organized Health Care Education/Training Program | Wilson, NC | $45.22 | 3 |
| , MD | Nephrology | Austin, TX | $44.76 | 2 |
| , M.D | Internal Medicine | San Antonio, TX | $44.76 | 3 |
| , MD | Nephrology | Pinehurst, NC | $44.51 | 3 |
| , MD | Nephrology | Austin, TX | $44.47 | 2 |
| , MD | Nephrology | Lansing, MI | $44.40 | 3 |
| , M.D | Nephrology | Nashville, TN | $44.38 | 2 |
| , MD | Nephrology | Columbia, SC | $44.33 | 3 |
| , D.O | Nephrology | Vineland, NJ | $44.28 | 2 |
Manufacturing Companies
- SANOFI-AVENTIS U.S. LLC $131,370
- GENZYME CORPORATION $26,710
Product Information
- Type Drug
- Total Payments $158,080
- Total Doctors 1,251
- Transactions 2,288
About RENVELA
RENVELA is a drug associated with $158,080 in payments to 1,251 healthcare providers, recorded across 2,288 transactions in the CMS Open Payments database. The primary manufacturer is SANOFI-AVENTIS U.S. LLC.
Payment data is available from 2017 to 2019. In 2019, $25,664 was paid across 8 transactions to 1 doctors.
The most common payment nature for RENVELA is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($79,829, 50.5% of total).
RENVELA is associated with 1 research study, including "Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease" ($5,498).